Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Edwards Lifesciences
EW
$47.6B
| $1.25B | 0.54% |
12,087,045
-903,071
| -7% | -$85.1M |
|
|
27
DexCom
DXCM
$27.6B
| $1.22B | 0.52% |
11,474,400
+3,998,492
| +53% | +$384M |
|
28
Sherwin-Williams
SHW
$78.3B
| $1.22B | 0.52% |
4,494,738
+249,915
| +6% | +$68.5M |
|
29
KLA
KLAC
$275B
| $1.2B | 0.51% |
36,874,980
+642,600
| +2% | +$20.6M |
|
30
SS&C Technologies
SSNC
$17.8B
| $1.18B | 0.51% |
16,442,924
-1,259,475
| -7% | -$92.1M |
|
31
Fidelity National Information Services
FIS
$21.5B
| $1.15B | 0.49% |
8,124,991
+53,444
| +0.7% | +$7.94M |
|
32
Eli Lilly
LLY
$1.07T
| $1.12B | 0.48% |
4,871,740
-140,005
| -3% | -$28.1M |
|
33
Abbott
ABT
$180B
| $1.11B | 0.48% |
9,574,882
+269,154
| +3% | +$31.4M |
|
34
LPL Financial
LPLA
$26.3B
| $1.07B | 0.46% |
7,921,775
-138,382
| -2% | -$20.1M |
|
35
Home Depot
HD
$332B
| $1.06B | 0.46% |
3,333,880
-236,470
| -7% | -$75.2M |
|
36
TE Connectivity
TEL
$58.8B
| $1.06B | 0.45% |
7,814,034
+300,641
| +4% | +$40.3M |
|
37
ASML
ASML
$675B
| $1.04B | 0.45% |
1,509,368
+179,923
| +14% | +$119M |
|
38
Walt Disney
DIS
$165B
| $1.03B | 0.44% |
5,849,068
+338,377
| +6% | +$60.9M |
|
39
Honeywell
HON
$77.1B
| $1.02B | 0.44% |
4,917,893
-169,944
| -3% | -$35.9M |
|
40
Accenture
ACN
$89.9B
| $1.01B | 0.43% |
3,428,300
-64,690
| -2% | -$18.5M |
|
|
CTLT
41
DELISTED
CATALENT, INC.
CTLT
| $1B | 0.43% |
9,281,132
-1,006,038
| -10% | -$108M |
|
42
Broadridge
BR
$17.2B
| $982M | 0.42% |
6,078,082
-316,242
| -5% | -$50.5M |
|
|
ZEN
43
DELISTED
ZENDESK INC
ZEN
| $978M | 0.42% |
6,778,628
-190,865
| -3% | -$27M |
|
44
Ferguson
FERG
$44.7B
| $977M | 0.42% |
7,034,616
+846,008
| +14% | +$112M |
|
45
CoStar Group
CSGP
$11.3B
| $970M | 0.42% |
11,717,971
-3,314,729
| -22% | -$287M |
|
46
Aon
AON
$77.3B
| $963M | 0.41% |
4,034,958
-791,722
| -16% | -$193M |
|
47
T-Mobile US
TMUS
$193B
| $962M | 0.41% |
6,639,483
-331,051
| -5% | -$45.6M |
|
48
Autodesk
ADSK
$44.3B
| $961M | 0.41% |
3,292,334
-59,211
| -2% | -$16.9M |
|
49
McDonald's
MCD
$188B
| $960M | 0.41% |
4,155,447
-1,014,055
| -20% | -$236M |
|
50
Thermo Fisher Scientific
TMO
$211B
| $950M | 0.41% |
1,883,099
-261,486
| -12% | -$123M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.